Cargando…

Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin

BACKGROUND: Lytic reactivation of EBV has been reported to play an important role in human diseases, including NPC carcinogenesis. Inhibition of EBV reactivation is considered to be of great benefit in the treatment of virus-associated diseases. For this purpose, we screened for inhibitory compounds...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chung-Chun, Fang, Chih-Yeu, Cheng, Yu-Jhen, Hsu, Hui-Yu, Chou, Sheng-Ping, Huang, Sheng-Yen, Tsai, Ching-Hwa, Chen, Jen-Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217310/ https://www.ncbi.nlm.nih.gov/pubmed/28056971 http://dx.doi.org/10.1186/s12929-016-0313-9

Ejemplares similares

The Synergistic Effect of Chemical Carcinogens Enhances Epstein-Barr Virus Reactivation and Tumor Progression of Nasopharyngeal Carcinoma Cells
por: Fang, Chih-Yeu, et al.
Publicado: (2012)

Reactive Oxygen Species Mediate Epstein-Barr Virus Reactivation by N-Methyl-N’-Nitro-N-Nitrosoguanidine
por: Huang, Sheng-Yen, et al.
Publicado: (2013)

Epstein–Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells
por: Huang, Sheng-Yen, et al.
Publicado: (2017)

Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells
por: Wu, Chung-Chun, et al.
Publicado: (2018)

EBV reactivation as a target of luteolin to repress NPC tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2016)

The Dietary Flavonol Kaempferol Inhibits Epstein–Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells
por: Wu, Chung-Chun, et al.
Publicado: (2022)

Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma
por: Chiu, Shih-Hsin, et al.
Publicado: (2014)

Epstein–Barr Virus (EBV) Rta-Mediated EBV and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivations in 293 Cells
por: Chen, Yen-Ju, et al.
Publicado: (2011)

Epstein–Barr Virus DNase (BGLF5) induces genomic instability in human epithelial cells
por: Wu, Chung-Chun, et al.
Publicado: (2010)

Stress-Induced Epstein-Barr Virus Reactivation
por: Sausen, Daniel G., et al.
Publicado: (2021)

Epstein‐Barr Virus‐encoded Latent Membrane Protein 1 Co‐expresses with Epidermal Growth Factor Receptor in Nasopharyngeal Carcinoma
por: Sheen, Tzung‐Shiahn, et al.
Publicado: (1999)

Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis
por: Da Cunha, Teresa, et al.
Publicado: (2022)

Epstein-Barr Virus BGLF4 Kinase Retards Cellular S-Phase Progression and Induces Chromosomal Abnormality
por: Chang, Yu-Hsin, et al.
Publicado: (2012)

Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
por: Xu, Miao, et al.
Publicado: (2019)

The ESCRT Machinery Is Recruited by the Viral BFRF1 Protein to the Nucleus-Associated Membrane for the Maturation of Epstein-Barr Virus
por: Lee, Chung-Pei, et al.
Publicado: (2012)

Anticonvulsant Hypersensitivity Syndrome Associated with Epstein-Barr Virus Reactivation
por: Chang, Jae Yong, et al.
Publicado: (2007)

Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Gorres, Kelly L., et al.
Publicado: (2016)

The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
por: Sun, Cong, et al.
Publicado: (2021)

Upregulation of Endocan by Epstein-Barr Virus Latent Membrane Protein 1 and Its Clinical Significance in Nasopharyngeal Carcinoma
por: Yu, Ping-Hung, et al.
Publicado: (2013)

Maternal depressive symptoms related to Epstein-Barr virus reactivation in late pregnancy
por: Zhu, Peng, et al.
Publicado: (2013)

Effects of Epstein-Barr Virus Infection on the Risk and Prognosis of Primary Laryngeal Squamous Cell Carcinoma: A Hospital-Based Case-Control Study in Taiwan
por: Lee, Li-Ang, et al.
Publicado: (2021)

CryoEM structure of the tegumented capsid of Epstein-Barr virus
por: Li, Zhihai, et al.
Publicado: (2020)

Epstein–Barr Virus History and Pathogenesis
por: Yu, Hui, et al.
Publicado: (2023)

A Molecular Link between Malaria and Epstein–Barr Virus Reactivation
por: Chêne, Arnaud, et al.
Publicado: (2007)

Epstein–Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity
por: Nagata, Keiko, et al.
Publicado: (2020)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

REACTIVATION OF EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH COVID-19
por: ALMAGUER, ANGELICA, et al.
Publicado: (2022)

Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients
por: Bernal, Keishanne Danielle E., et al.
Publicado: (2023)

Epstein–Barr virus reactivation‐related meningoencephalitis with transverse myelitis in pregnancy
por: Nguyen, Andrew Dang Khai, et al.
Publicado: (2023)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

In Vitro and In Vivo Anti-tumoral Effects of the Flavonoid Apigenin in Malignant Mesothelioma
por: Masuelli, Laura, et al.
Publicado: (2017)

EGCG Inhibits Proliferation, Invasiveness and Tumor Growth by Up-Regulation of Adhesion Molecules, Suppression of Gelatinases Activity, and Induction of Apoptosis in Nasopharyngeal Carcinoma Cells
por: Fang, Chih-Yeu, et al.
Publicado: (2015)

Epstein-Barr Virus and Neurological Diseases
por: Zhang, Nan, et al.
Publicado: (2022)

Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation
por: Zhou, Jing-Rui, et al.
Publicado: (2021)

A Large-Scale Seroprevalence of Epstein-Barr Virus in Taiwan
por: Chen, Chao-Yu, et al.
Publicado: (2015)

The oncogenic role of Epstein–Barr virus‐encoded microRNAs in Epstein–Barr virus‐associated gastric carcinoma
por: Zhang, Jinglin, et al.
Publicado: (2017)

Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis
por: Li, Hongde, et al.
Publicado: (2016)

Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
por: Anderson, Abbie G., et al.
Publicado: (2019)

Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
por: Gold, Jeffrey E., et al.
Publicado: (2021)

Association between Epstein‐Barr‐Virus reactivation and development of Long‐COVID fatigue
por: Rohrhofer, Johanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kp1aepr6po7sqp30g8cdh2oo43